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Abstract
Background: In many countries, smoking remains the leading preventable cause of death. In North America,
reductions in population smoking levels are stabilising and, in recent years, those involved in tobacco control
programming have turned their attention to particular segments of society that are at greatest risk for tobacco use.
One such group is people with mental illness. A picture of tobacco use patterns among those with mental illness
is beginning to emerge; however, there are several unanswered questions. In particular, most studies have been
limited to particular in-patient groups. In addition, while it is recognised that men and women differ in relation to
their reasons for smoking, levels of addiction to nicotine, and difficulties with cessation, these sex and gender
differences have not been fully explored in psychiatric populations.
Methods: Community residents with serious mental illness were surveyed to describe their patterns of tobacco use
and to develop a gender-specific profile of their smoking status and its predictors.
Results: Of 729 respondents, almost one half (46.8%) were current tobacco users with high nicotine dependence
levels. They spent a majority of their income on tobacco, and reported using smoking to cope with their
psychiatric symptoms. Current smokers, compared with non-smokers, were more likely to be: diagnosed with a
schizophrenia spectrum disorder (rather than a mood disorder); male; relatively young; not a member of a
racialised group (e.g., Aboriginal, Asian, South Asian, Black); poorly educated; separated or divorced; housed in a
residential facility, shelter, or on the street; receiving social assistance; and reporting co-morbid substance use.
There is evidence of a gender interaction with these factors; in the gender-specific multivariate logistic regression
models, schizophrenia spectrum disorder versus mood disorder was not predictive of women’s smoking, nor was
education, marital status or cocaine use. Women, and not men, however, were more likely to be smokers if they
were young and living in a residential facility.
Conclusion: For men only, the presence of schizophrenia spectrum disorder is a risk factor for tobacco use. Other
factors, of a social nature, contribute to the risk of smoking for both men and women with serious mental illness.
The findings suggest that important social determinants of smoking are “gendered” in this population, thus
tobacco control and smoking cessation programming should be gender sensitive.
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Background
In many countries, smoking remains the leading
preventable cause of death. In North America, reduc-
tions in smoking rates are stabilising and, in recent
years, those involved in tobacco control programming
have turned their attention to particular segments
of society that are at greatest risk for tobacco use,
especially people with mental illness.
An appreciation of the high rate of tobacco use by
those with mental illness is emerging. In a USA popula-
tion-based study of 4,441 respondents aged 15-54 years,
Lasser and colleagues [1] reported that current smoking
rates for those with no mental illness, lifetime mental
illness, or mental illness in the past month were 22.5%,
34.8%, and 41.0%, respectively. The burden of tobacco
use appears to be disproportionally borne by those with
mental illness. Dani and Harris reported that 7% of
Americans have a mental illness, and that this relatively
small group consumes 34% of all cigarettes sold in the
USA [2]. Those with mental illness are noted to have a
higher “all cause” mortality rate compared with the gen-
eral population; although suicide and accidents contri-
bute to the high rate, very high mortality rates due to
cardiovascular disease are apparent [3].
Those with serious mental illness (SMI) (i.e., those
individuals who require long-term treatment for their
illness) are at particular risk for tobacco use. Previous
studies have found very high smoking rates among
selected populations of people with SMI, including psy-
chiatric outpatients [4], patients in state mental hospitals
in the USA, and patients in several other countries [5,6].
There is some evidence that smoking rates vary by psy-
chiatric diagnosis, with individuals with a diagnosis of
schizophrenia having the highest tobacco use rate [7].
Sex and gender differences in tobacco use have been
the focus of numerous studies. It is increasingly recog-
nised that men and women differ in relation to their
reasons for smoking, levels of addiction to nicotine, and
difficulties with cessation. Some of these differences may
be attributed to social factors (gender) while others may
be attributable to biological factors (sex) [8]. These sex
and gender differences have not been fully explored in
psychiatric populations.
Although it is now recognised that substance use dis-
orders are prevalent among people with SMI, tobacco
use is often not included in substance use screening [9],
even though there are emerging links being made
between tobacco use and other substance use and in
some instances with antipsychotic medication use [10].
There is limited understanding of whether those with
SMI who use tobacco are also more likely to use other
substances, and if so, which substances are most fre-
quently used.
A picture of tobacco use patterns among those with
SMI is emerging; however, there are several unanswered
questions. In particular, much of the data collected have
been limited to particular clinics or in-patient groups,
and few researchers have disaggregated their data by
gender. Given recent trends of deinstitutionalisation,
further study is warranted of tobacco use patterns
among men and women living in the community with
SMI. There also is a need to explore how tobacco use
varies by diagnosis, whether it differs by symptomatol-
ogy and other substance use, and whether social-
environmental factors are salient.
The purpose of this study was to determine the rate of
tobacco use among people with SMI accessing commu-
nity-based mental health services, and to learn more
about the factors associated with their tobacco use. The
specific objectives of the research were to: (a) describe
the profile of tobacco use among people with SMI, (b)
determine whether tobacco use differs by psychiatric
diagnosis and by gender, and (c) determine the extent
to which co-morbid substance use and social-environ-
mental factors are associated with smoking status.
Methods
We conducted a cross-sectional survey in which we tar-
geted all adults with SMI who received services from
community-based mental health teams in Vancouver,
Canada. The vast majority of non-institutionalised per-
sons with a diagnosis of SMI, in this city, are followed
by one of these teams (they provide services to almost
6,000 people, more than 1% of Vancouver’s population).
Each mental health team provides psychiatric assess-
ment and comprehensive treatment through drop-in
and outreach services for people in their catchment
area. Services include medication management, indivi-
dual and group therapy, rehabilitation, and education.
Many clients receive additional support in the form of
rehabilitation programming or housing through con-
tracted agencies.
Sample
We sought to obtain a representative sample of people
with SMI receiving community mental health services.
Because of confidentiality concerns (i.e., disclosure of
names and diagnoses without consent), however, we
were not permitted to draw a random sample from the
population of people receiving services. Consequently,
we recruited voluntary participants who were receiving
services from seven of the eight mental health teams.
Eligible participants were individuals whose health
records were flagged as active and who received care
from an adult care program. All study participants were
living in the community and were able to communicate
Johnson et al. BMC Psychiatry 2010, 10:101
http://www.biomedcentral.com/1471-244X/10/101
Page 2 of 12
and be understood in English, Mandarin, Cantonese, or
Punjabi.
Procedures
The research staff visited each community mental health
team, provided information about the study, answered
questions, and negotiated strategies to access eligible
participants. A research assistant recruited participants
at the mental health team offices during regular operat-
ing hours. The participants were introduced to the sur-
vey either through the reception desk personnel or their
case managers. The participants could “self refer” to the
research staff in response to brochures and flyers avail-
able in the office waiting areas. The research staff
explained the study in detail, obtained written, fully
informed consent, and administered the questionnaire
[11]. Upon completion of the questionnaire, the partici-
pants received a $10 gift certificate for a local grocery
store. Data collection occurred between October 2005
and October 2006, with each mental health team
involved for approximately 4-6 months.
Ethical approval
Ethical approval was obtained from the Behavioural
Research Ethics Board of the University of British
Columbia. Approval to conduct the research was
obtained from Vancouver Coastal Health, Vancouver
Community Health Service Delivery Area.
Measures
The questionnaire, which included several scales and
items, requiring 20-45 minutes to complete, was admi-
nistered by the research staff.
Demographics
The demographic items included: age ("What is your
birth date?”), gender ("Do you identify as male, female,
trans-gendered or other?”), and ethnic/cultural back-
ground ("What would you say is your main ethnic or
cultural background?”). The information from this item
was used to create a “racialised group” variable ("no” or
“yes”). The use of this term is meant to construe the
belief that racial classifications are socially constructed
and embedded in Eurocentric notions of inferiority,
colonization, and prestige [12]. In the study community,
people who are Aboriginal, Asian, South Asian or Black
tend to be racialised, which has implications for their
health [13]. The other demographic variables included:
marital status ("What is your current marital status?”),
current living situation ("Who do you live with? Alone,
with family, friend(s), group home, or other?”), and
housing type ("What kind of housing do you live in?”
Independent, semi-independent, residential, shelter/hos-
tel, no fixed address, other?), financial support ("In the
last month, where have you received money or financial
support from? Earned income/paid work, social
assistance/welfare, disability benefits, unemployment
insurance, pension, savings, alimony/child support,
family contribution, panhandling, other”), disposable
income ("After paying for housing and food last month,
how much money did you have to spend on yourself?”),
and income “prioritizing strategies” ("When you have to
make decisions about spending money on cigarettes,
have you ever chosen to give up anything so that you
would have enough tobacco? Have you given up buying
food? Coffee? Bus fare? Rent? Medication? Anything
else?”).
Psychiatric Diagnosis
Not all of the participants (15.1%) provided permission
to access their medical records. These individuals’ diag-
nostic information was limited to a self-report of the
psychiatric diagnosis ("What is your diagnosis?”). For
the remainder who provided consent (84.9%), informa-
tion about their diagnoses was collected from their
existing mental health team medical record. Once
referred to a community mental health team, all clients
are assessed by one of the team’s psychiatrists. The psy-
chiatrists typically base their diagnoses on findings of a
one-hour assessment interview (that includes mental
status examination and case history). DSM IV criteria
are used to guide the diagnostic process. A diagnosis is
recorded at the time of the client’s intake to community
mental health services, and then modified as required.
For the purposes of this study, the most current diagno-
sis was recorded.
For the purpose of the analysis, we classified the speci-
fic diagnoses as schizophrenia spectrum disorders, mood
disorders, or anxiety disorders. A diagnosis of a schizo-
phrenia spectrum disorder included schizophrenia and
its subtypes, schizoaffective disorder, delusional disorder,
or psychosis not otherwise specified. Mood disorders
included diagnoses of bipolar disorder, major depres-
sion, manic depression or dysthymia. Anxiety disorders
included diagnoses of obsessive compulsive disorder,
generalized anxiety disorder, and panic disorder.
Psychiatric Symptoms
Psychiatric symptoms were assessed with the Brief
Symptom Inventory (BSI) [14], which has been validated
for use with people living with schizophrenia and is pre-
ferred over other scales of psychopathology because it is
relatively non-invasive, quick to administer, and suitable
for use by research staff [15]. The 18-item scale mea-
sures anxiety (e.g., nervousness or shakiness inside),
depression (e.g., feeling lonely), and general somatic
symptoms (e.g., feeling weak in parts of your body)
using a 5-point scale to measure the extent of distress
experienced over the past week; the response options
were: “not at all,” “a little bit,” “moderately,” “quite a
bit,” and “extremely.” The internal consistency for the
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Global Severity Index (GSI) has been reported to be
strong with a coefficient alpha of .89 [15]. In this study,
the scale had a coefficient alpha of .92. We followed the
prescribed BSI scoring method: the raw GSI score was
calculated by adding the 18 items [16]. If participants
had more than 2 item responses missing for any sub-
scale, their scores were not calculated and the case was
treated as missing. When participants had 1 or 2 miss-
ing items, values were imputed by rounding the mean of
the completed items to the nearest whole number. The
GSI scores were standardized using T scores with a
mean of 50 and an SD of 10 to determine “caseness.”
Those with GSI scores of 63 or greater were deemed to
be at positive risk for psychological distress [14,16].
Tobacco Use Patterns
Smoking status was determined by asking the partici-
pants if they had “ever” smoked, whether they had
smoked more than 100 cigarettes in their lifetime, when
they smoked their last cigarette, and if they smoked
every day [17]. The participants were classified as non-
smokers (had never smoked or smoked less than 100
cigarettes), former smokers (had smoked more than 100
cigarettes, but had not smoked in the past 30 days), or
current smokers (had smoked more than 100 cigarettes
and had smoked in the past 30 days). A binary variable
was created with current smoker versus former/never
smoker. The participants also were asked, “Do you con-
sider yourself a current smoker?” (The response options
were “yes” or “no.”) There was excellent agreement
between the classification of smoking status based on
the number of cigarettes smoked in the past 30 days
and the participants’ self-reported smoking status
(Kappa = .97).
Tobacco use patterns and practices were measured by
determining the amount of tobacco smoked each day,
the age of smoking initiation [18] and reasons for
tobacco use [19]. Physical health consequences of
tobacco use were assessed with the item, “Do you have,
or have you had symptoms that you believe were caused
or made worse by smoking?” [20]. Items also were
included to determine: the primary sources of tobacco
procurement ("As you know, cigarettes are expensive
and people get them in different ways. Where do you
get yours?”), average weekly expenditure on tobacco
("About how much money do you spend on tobacco per
week?”), and type of cigarettes smoked ("What kind of
cigarettes do you smoke... store bought, roll your own,
butts, other?”).
Nicotine dependence was measured with the Fager-
ström Test for Nicotine Dependence (FTND) [20]. This
test is appropriate for the assessment of nicotine depen-
dence in smokers with schizophrenia [21]. The coding
algorithm yields a total score of 0-10. Scores above 6
are indicative of a high level of dependence. Although
widely used, the internal consistency for the FTND scale
has been borderline (Cronbach’s alpha .67) [22]; in this
study, the Cronbach’s alpha was .50. In addition to
using this scale, the participants were asked to rate their
tobacco addiction using a self-rated addiction scale of 0-
10, where 0 was “not at all” addicted and 10 was “extre-
mely” addicted. They also were asked about using
tobacco to manage their psychiatric symptoms: “Some
people use smoking to cope with their symptoms, such
as having anxiety or hearing voices. How often do you
smoke to cope with symptoms?” The item was scored
with a 4-point scale rated as “not at all,” “a little,”
“somewhat,” or “a great deal.” Another open-ended
question asked, “What symptoms do cigarettes help you
manage?”
Substance Use
Comorbid substance use was assessed with items from
the substance use section of the Addiction Severity
Index (ASI), originally developed for clinical purposes
[23], [24]. The ASI has seven sections measuring various
aspects of an individual’s life that may be affected by
substance use. For research purposes, the use of indivi-
dual items from the substance use section of the ASI
has been found to be reliable, valid, and valuable [25].
The participants were asked, “How many days in the
past month (last 30 days) did you use...any alcohol?
Alcohol to get drunk? Heroin (smack, junk)? Metha-
done? Opium, codeine, or pain killers like Tylenol 3?
Sedatives, hypnotics or tranquilizers like Valium or
Xanax? Cocaine or crack? Amphetamines, like speed, E
or meth? Marijuana (weed, pot)? Hallucinogens, like
LSD or mushrooms? Inhalants, like glue, paint thinner
or gas? Any other substances? Specify.” The ASI results
were reported as number of days and were categorized
into “no, none” or “yes, 1 or more days” because of the
participants’ infrequent regular use and the distribu-
tional properties of their responses [26].
Analysis
A total of 788 people participated in the study, which
represents approximately 20% of the clients who received
care from the 7 community mental health teams. The
data from these clients were cleaned and screened before
analysis to ensure missing data were random in occur-
rence and that all data were within their excepted ranges.
Responses from 59 (7.5%) individuals were excluded
because they did not have a clear psychiatric diagnosis.
Descriptive analysis of the sample (N = 729) employed
chi square tests to determine the associations between
psychiatric diagnosis and the categorical study variables.
Independent sample t-tests employing Levine’s test for
equality of variance were employed to examine the rela-
tionships between psychiatric diagnosis and the continu-
ous variables. We employed Hosmer and Lemeshow’s
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model-building process to determine the variables that
were associated with current smoking status (current
smoker vs. former/never smoker) [27]. First, we
employed univariate logistic regression analyses to iden-
tify the study variables associated with smoking status
and conducted these analyses for the entire sample and
for men and women, separately. In the second step, vari-
ables that were associated with smoking status at p ≤ .25
were included in the multivariate logistic regression mod-
els (all participants and gender-specific). To obtain the
most parsimonious and stable models, we then trimmed
them by removing statistically non-significant variables
sequentially by examining the Wald statistic and compar-
ison of the likelihood ratios. If the likelihood ratio test
was significant when a non-significant variable was
removed (i.e., p < .05), then the variable was added back
to the model. Once the main effects models were fina-
lized, all possible interactions between diagnostic cate-
gory and the other variables were examined. All analyses
were conducted with IBM SPSS Statistics 18.
Results
Demographics
About one half (51.2%) of the participants were women;
26.6% were of a racialised group; 76.5% had a high
school or better education; 63.0% reported being single
and never married; 71.0% lived in independent, private
houses or apartments; 52.9% lived alone; and the major-
ity (56.7%) received government disability benefits. The
average age of the participants was 47.4 years (SD =
12.1) (see Table 1). To determine if those who provided
access to their records differed from those who did not,
we compared the two groups by the variables listed in
Table 1 and found no statistically significant differences.
Psychiatric Diagnostic Category
The majority (59.8%) of the participants had a diagnosis
of schizophrenia spectrum disorder and the remainder
had mood (38.1%) or anxiety (2.1%) disorders. For the
subsequent analyses, we combined those with a mood
disorder or anxiety disorder into a single group. The
participants with schizophrenia spectrum disorder were
more likely to be male, single and never married, live in
a residential facility or group residential home, and
receive social assistance (see Table 1).
The mean BSI scores for the sample were: somatisa-
tion = 10.8 (SD = 4.3), depression = 12.0 (SD = 5.4),
and anxiety = 11.8 (SD = 5.3) (see Table 1). In terms of
‘caseness’ of psychological distress, 12.2% of the partici-
pants surpassed the GSI cutoff value of 63 or greater. In
general, those with mood or anxiety disorders had
greater symptomatology; 15.4% of this group, compared
with 10.0% of those with schizophrenia spectrum disor-
der met the ‘caseness’ criterion.
Tobacco Use
Almost one half (46.8%) of the participants were current
smokers (see Table 1); 57.5% of the men and 35.6% of
the women were current smokers. The prevalence of
participants who reported “ever smoking” was 89.3%.
Most (53.8%) of the participants began smoking at 15
years of age or younger. Of those who currently smoked,
the average number of cigarettes smoked daily was 20.2
cigarettes (SD = 13.9), and the main reasons reported
for smoking were addiction (36.8%) and anxiety (37.1%).
The majority of current smokers reported smoking
every day (96.2%), had smoked for 30 years, on average,
and were self-identified “chain smokers” (61.5%). Almost
one third of the current smokers reported lighting a sec-
ond cigarette while the first cigarette was still burning
(27.4%). The current smokers’ median FTND score was
6.0. In relation to their self-rated addiction, the mean
response was = 7.4 (SD = 2.5) on a scale of 0 to 10.
Although the self-rated addiction scores were not signif-
icantly associated with the FTND scores (Spearman rho
= .03, p = .70), they were associated with the average
number of cigarettes smoked per day (Spearman rho =
.44, p < .001) and age of smoking initiation (Spearman
rho = -.12, p = .030). About one half (51.5%) of the par-
ticipants revealed that they had experienced symptoms
of a disease or illness that were caused or worsened by
their smoking.
Almost all (92.2%) of the current smokers reported
“buying tobacco from a store,” which was the most
common method of procuring tobacco, although it was
not exclusive to other methods including “receiving
tobacco from friends” (53.3%), “bumming cigarettes
from people” (39.6%), “sharing someone else’s” (39.5%),
and “picking up butts” (30.5%) (i.e., picking up cigarette
ends from sidewalks and ashtrays and smoking the ends
or re-rolling the salvaged tobacco). The average amount
of money spent per week on tobacco was (CAD) $40.50
(SD = $25.70). Almost one half (41.2%) of the current
smokers indicated that they had, on occasion, given up
buying food so that they would have enough tobacco.
Many of the current smokers (68.8%) reported that
they coped with their psychiatric symptoms by smoking
and 30.3% reported doing this “a great deal.” Those who
answered affirmatively indicated that cigarettes helped
them manage multiple symptoms including anxiety/
stress (95.9%), depression (20.6%), and hearing voices/
delusions (10.0%).
Bivariate associations with current smoking status
The men with a schizophrenia spectrum disorder, in the
sample, were 1.8 times more likely to be current smo-
kers than were those men with a mood or anxiety disor-
der (see Table 1). The association between diagnostic
category and smoking status was not significant for the
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Table 1 Demographic Characteristics and Participants’ Substance Use by Diagnostic Category
Characteristic All Schizophrenia
Spectrum
Disorder
Mood or
Anxiety
Disorder1
Differences
(N = 729) (n = 436) (n = 293)
(100%) (59.8%) (40.2%)
f % f % f % c2 (df), sig.2
Gender (n = 719) 8.0 (1), p = .005
Male 351 48.8 228 53.3 123 42.3
Female 368 51.2 200 46.7 168 57.7
Racialised Group (n = 680) 0.3 (1), p = .592
No (e.g., white/European) 499 73.4 300 74.3 199 72.1
Yes (e.g., Aboriginal/Asian/South Asian/Black) 181 26.6 104 25.7 77 27.9
Education (n = 723) 1.1 (1), p = .289
Less than high school 170 23.5 108 25.0 62 21.3
High school or more 553 76.5 324 75.0 229 78.7
Marital Status (n = 719) 18.9 (3), p = <.001
Single and never married 453 63.0 289 67.5 164 56.4
Separated/Divorced 159 22.1 92 21.5 67 23.0
Married (spouse or common law partner) 79 11.0 30 7.0 49 16.8
Widowed 28 3.9 17 4.0 11 3.8
Housing (n = 723) 28.5 (3), p <.0001
Independent (private house or apartment) 513 71.0 279 64.6 234 80.4
Residential facility (licensed/boarding) 102 14.1 81 18.8 21 7.2
Semi-independent (subsidy/supportive care) 94 13.0 66 15.3 28 9.6
Shelter/hostel/no housing 14 1.9 6 1.4 8 2.7
Living Arrangement (n = 724) 26.4 (3), p <.0001
Lives alone 383 52.9 240 55.6 143 49.0
Lives with family 170 23.5 87 20.1 83 28.4
Group home resident 101 14.0 76 17.6 25 8.6
Lives with roommate/friend(s)/girlfriend/boyfriend 70 9.7 29 6.7 41 14.0
Sources of Financial Support (multiple responses permitted, n = 714)
Disability benefits (yes v. no) 405 57.0 235 55.8 170 58.8 0.7 (1), p = .397
Canada Pension Plan or other pension (yes v. no) 165 23.1 102 24.1 63 21.7 0.4 (1), p = .525
Earned income/paid work (yes v. no) 167 23.4 89 21.0 78 26.9 3.0 (1), p = .082
Social assistance/welfare (yes v. no) 119 16.7 87 20.5 32 11.0 10.5 (1), p = .001
Family contribution (yes v. no) 110 15.4 58 13.7 52 17.9 2.1 (1), p = .150
Smoking Status (n = 729) 13.1 (2), p = .001
Current 341 46.8 226 51.8 115 39.2
Former 156 21.4 91 20.9 65 22.2
Never 232 31.8 119 27.3 113 38.6
Any Alcohol Intoxication (in past month) (n = 716) 2.9 (1), p = .088
Yes 63 8.8 31 7.2 32 11.2
No 653 91.2 399 92.8 254 88.8
Any Cocaine Use (in past month) (n = 716) 0.0 (1), p = 1.000
Yes 28 3.9 17 4.0 11 3.8
No 688 96.1 412 96.0 276 96.2
Any Cannabis Use (in past month) (n = 717) 2.3 (1), p = .128
Yes 92 12.8 48 11.2 44 15.3
No 625 87.2 382 88.8 243 84.7
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women. The GSI score (≥ 63 vs. < 63; ‘caseness’) was
not statistically significantly associated with smoking
(see Table 2).
The men were 2.5 times more likely to smoke than
were the women (see Table 2). For women, being young
was a risk factor (those 17-29 years of age were 2.8
times were more likely to smoke compared with those
60+ years of age). For men, the age group with the
greatest risk of smoking was the 50-59 years of age
group (OR = 2.4, 95% CI: 1.1-5.1).
Being a member of racialised group was protective
against smoking for the women only. White/European
women were 2.4 times more likely to smoke compared
with racialised women. Education was only significant
for the men; those with less than high school education
were about twice as likely to smoke compared with
those who were better educated. Compared with those
who were married, men who were separated or divorced
were 3.3 times more likely to smoke. Marital status and
education were not risk factors for the women.
The respondents who reported having no housing or
who lived in temporary shelters or hostels were very
likely to smoke (OR = 17.9; 95% CI: 2.3-13.7). There
were too few cases of people without housing to provide
a breakdown by gender. Other forms of housing, how-
ever, also placed the women at risk of smoking; specifi-
cally, women in residential facilities were 2.7 times more
likely to smoke than were women who lived indepen-
dently. Similarly, living with their family protected both
men and women from smoking (see Table 2).
The only form of financial support received that was
associated with smoking status was social assistance or
welfare. Both men and women who received this form
of support were thrice as likely to smoke compared with
those not on assistance.
Other substance use was associated with smoking sta-
tus. For men who used alcohol to intoxication in the
previous month, or who had used any cocaine or canna-
bis in the past month, current tobacco smoking was also
likely. For women, the only other substance use that was
associated with their smoking status was cannabis use
(OR = 5.2; 95% CI: 2.5-10.5) (see Table 2).
Multivariate associations with current smoking status
The multivariate gender-specific models revealed the
following. For the men, the significant predictors of
smoking status, adjusted for confounding, were: having
a schizophrenia spectrum disorder vs. a mood or anxiety
disorder (ORadjusted = 2.0; 95% CI: 1.2-3.3), having less
than a high school education (ORadjusted = 1.8; 95% CI:
1.0-3.1), being separated or divorced, rather than mar-
ried (ORadjusted = 3.8; 95% CI: 1.2-11.4), receiving social
assistance or welfare (ORadjusted = 2.6; 95% CI: 1.3-5.4),
and having used cannabis in the past month (ORadjusted
= 4.6; 95% CI: 2.2-10.0) (see Table 3). Being a member
of a racialised group and having used cocaine in the
past month had odds ratios that spanned unity; retain-
ing these variables in the model, however, improved the
model (the comparison of log-likelihood ratios for mod-
els with and without these variables were statistically
significant). The Nagelkerke R2 for this model, with
seven variables, was .23. The correct classification rates
were 63.8% for current smokers and 70.9% for non-smo-
kers; the overall correct classification rate was 67.0%.
For the women, the significant predictors of smoking
status were: age (17-29 years vs. 60+ years; ORadjusted =
2.8; 95% CI: 1.0-8.0), being white or of European origin
(ORadjusted = 2.5; 95% CI: 1.4-4.6), living in a residential
facility vs. independent living (ORadjusted = 2.7; 95% CI:
1.3-5.8), receiving social assistance or welfare (ORadjusted
= 3.3; 95% CI: 1.6-6.5), and having used cannabis in
the past month (ORadjusted = 3.2; 95% CI: 1.2-8.0) (see
Table 3). The Nagelkerke R2 for this model, with five
variables, was .17. The correct classification rates were
37.6% for current smokers and 86.9% for non-smokers;
the overall correct classification rate was 69.5%.
Discussion
It is noteworthy that almost one half of the study parti-
cipants were current smokers; this is almost three times
Table 1 Demographic Characteristics and Participants?’? Substance Use by Diagnostic Category (Continued)
Mean SD Mean SD Mean SD t (df), sig.
Age (years) (n = 721) 47.4 12.1 47.8 12.4 46.9 11.9 1.0 (719), p = .336
Brief Symptom Inventory (n = 715)
Somatic symptoms 10.8 4.3 10.6 4.1 11.1 4.6 -1.6 (566.1), p = .1003
Depression 12.0 5.4 11.5 4.9 12.8 6.0 -3.1 (522.4), p = .0023
Anxiety 11.8 5.3 11.3 4.9 12.6 5.8 -3.2 (533.1), p = .0023
Global Severity Index 34.7 13.2 33.4 12.1 36.6 14.5 -3.1 (533.6), p = .0023
1 Composed of participants with a mood disorder or an anxiety disorder (38.1% and 2.1% of the total sample, respectively).
2Continuity correction applied for crosstabulations with 1 degree of freedom.
3Levene’s Test for Equality of Variances significant; thus, equal variances not assumed for t-tests.
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Table 2 Bivariate Relationships between Smoking Status (Current vs. Former/Never) and Diagnostic Category,
Demographic Characteristics and Other Substance Use
Characteristic All Men Women
Odds Ratio 95% CI Odds Ratio 95% CI Odds Ratio 95% CI
Diagnostic Category1
Schizophrenia spectrum disorder 1.7** 1.2 - 2.3 1.8** 1.2 - 2.8 1.3 0.8 - 1.9
Mood or anxiety disorder (referent) 1.0 – 1.0 – 1.0 –
Gender
Men 2.5*** 1.8 - 3.3 – – – –
Women (referent) 1.0 – – – – –
Age Group
17-29 years 2.4* 1.2 - 4.7 1.6 0.6 - 4.3 2.8* 1.1 - 7.0
30-49 years 1.7* 1.1 - 2.6 1.8 0.9 - 3.7 1.1 0.6 - 2.0
50-59 years 2.3** 1.4 - 3.7 2.4* 1.1 - 5.1 1.8 0.9 - 3.4
60+ years (referent) 1.0 – 1.0 – 1.0 –
Racialised Group
No (e.g., white/European) 1.8** 1.3 - 2.6 1.4 0.9 - 2.4 2.4** 1.4 - 4.1
Yes (e.g., Aboriginal/Asian/South Asian/Black) (referent) 1.0 – 1.0 – 1.0 –
Education
Less than high school 1.8** 1.3 - 2.6 2.1** 1.3 - 3.4 1.2 0.7 - 2.1
High school or more (referent) 1.0 – 1.0 – 1.0 –
Marital Status
Single and never married 1.6 1.0 - 2.7 2.0 0.8 - 4.8 0.9 0.5 - 1.7
Separated/Divorced 2.0* 1.1 - 3.5 3.3* 1.2 - 8.9 1.4 0.7 - 2.8
Widowed 1.2 0.5 - 2.9 4.7 0.4 - 52.1 1.0 0.4 - 2.7
Married (spouse or common law partner) (referent) 1.0 – 1.0 – 1.0 –
Housing
Independent (private house or apartment) (referent) 1.0 – 1.0 – 1.0 –
Residential facility (licensed/boarding) 2.0** 1.3 - 3.0 1.4 0.7 - 2.5 2.7** 1.4 - 5.1
Semi-independent (subsidy/supportive care) 1.4 0.9 - 2.1 1.2 0.7 - 2.3 1.5 0.8 - 2.9
Shelter/hostel/no housing2 17.9** 2.3 -137.7 M – M –
Living Arrangement
Lives alone 2.2*** 1.5 - 3.1 2.1* 1.2 - 3.6 1.9* 1.1 - 3.3
Lives with family (referent) 1.0 – 1.0 – 1.0 –
Group home resident 3.4*** 2.0 - 5.6 2.4* 1.1 - 5.1 4.3*** 2.1 - 8.8
Lives with roommate/friend(s)/girlfriend/boyfriend 2.1* 1.2 - 3.7 2.7* 1.1 - 6.4 1.6 0.7 - 3.6
Sources of Financial Support (multiple responses permitted)
Disability benefits (yes v. no) 0.9 0.6 - 1.1 0.8 0.5 - 1.2 0.8 0.5 - 1.3
Canada Pension Plan or other pension (yes v. no) 0.7 0.5 - 1.1 0.6 0.4 - 1.0 1.0 0.6 - 1.6
Earned income/paid work (yes v. no) 0.8 0.5 - 1.1 0.7 0.4 - 1.1 0.8 0.5 - 1.3
Social assistance/welfare (yes v. no) 3.3*** 2.1 - 5.0 3.1*** 1.7 - 5.8 3.2*** 1.7 - 5.9
Family contribution (yes v. no) 0.8 0.5 - 1.2 0.9 0.4 - 1.9 1.0 0.6 - 1.6
Any Alcohol Intoxication (in past month)
Yes 2.2** 1.3 - 3.7 2.1* 1.0 - 4.2 1.4 0.5 - 3.5
No (referent) 1.0 – 1.0 – 1.0 –
Any Cocaine Use (in past month)
Yes 7.5*** 2.6 - 21.8 8.4** 1.9 - 36.3 3.7 0.9 - 20.6
No (referent) 1.0 – 1.0 – 1.0 –
Any Cannabis Use (in past month)
Yes 5.5*** 3.2 - 9.3 4.6*** 2.0 - 10.5 5.2*** 2.5 - 10.5
No (referent) 1.0 – 1.0 – 1.0 –
Brief Symptom Inventory (Global Severity Index)
< 63 (referent) 1.0 – 1.0 – 1.0 –
≥ 63 1.3 0.8-2.0 1.0 0.5 - 2.0 1.6 0.8 - 3.0
1 76 (38.0%) of the 200 women with schizophrenia spectrum disorders were current smokers. 55 (32.7%) of the 168 women with mood or anxiety disorders were
current smokers. 143 (62.7%) of the 228 men with schizophrenia spectrum disorders were current smokers. 59 (48%) of the 123 men with a mood or anxiety
disorders were current smokers.
2Treated as missing in gender-specific models because of small numbers.
*p < .05; **p < .01; ***p < .001.
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Table 3 Multivariate Relationships between Smoking Status (Current vs. Former/Never) and Diagnostic Category,
Demographic Characteristics and Other Substance Use
Characteristic All Men Women
Adjusted Odds
Ratio
95%
CI
Adjusted Odds
Ratio
95% CI Adjusted Odds
Ratio
95%
CI
Diagnostic Category
Schizophrenia spectrum disorder 1.5* 1.0 -
2.1
2.0* 1.2 - 3.3 NI1 –
Mood or anxiety disorder (referent) 1.0 – 1.0 – – –
Gender
Men 2.0*** 1.4 -
2.9
– – – –
Women (referent) 1.0 – – – – –
Age Group
17-29 years 2.6* 1.2 -
5.8
NI – 2.8* 1.0 -
8.0
30-49 years 1.4 0.8 -
2.5
– – 1.0 0.5 -
2.0
50-59 years 1.8* 1.0 -
3.1
– – 1.7 0.9 -
3.5
60+ years (referent) 1.0 – 1.0 –
Racialised Group
No (e.g., white/European) 1.8** 1.2 -
2.7
1.5 0.8 - 2.6 2.5** 1.4 -
4.6
Yes (e.g., Aboriginal/Asian/South Asian/Black)
(referent)
1.0 – 1.0 – 1.0 –
Education
Less than high school – – 1.8* 1.0 - 3.1 NI –
High school or more (referent) – – 1.0 – – –
Marital Status2
Single and never married 1.0 0.5 -
1.7
1.7 0.6 - 4.4 NI –
Separated/Divorced 1.8 1.0 -
3.5
3.8* 1.2 -
11.4
– –
Widowed 1.4 0.5 -
4.1
C – – –
Married (spouse or common law partner)
(referent)
1.0 – 1.0 – – –
Housing
Independent (private house or apartment)
(referent)
1.0 – NI – 1.0 –
Residential facility (licensed/boarding) 1.8* 1.1 -
3.1
– – 2.7** 1.3 -
5.8
Semi-independent (subsidy/supportive care) 1.6 1.0 -
2.6
– – 1.9 0.9 -
3.8
Shelter/hostel/no housing M3 – – – M –
Source of Financial Support
Social assistance/welfare (yes v. no) 2.7*** 1.6 -
4.4
2.6* 1.3 - 5.4 3.3*** 1.6 -
6.5
Any Cocaine Use (in past month)
Yes – – 4.9 1.0 -
24.0
– –
No (referent) – – 1.0 – – –
Any Cannabis Use (in past month)
Yes 4.5*** 2.5 -
8.1
4.6*** 2.2 -
10.0
3.2* 1.2 -
8.0
No (referent) 1.0 – 1.0 – 1.0 –
1 Not included in the model because the bivariate relationship (unadjusted odds ratio) had a p value ≥ .25 (NI).
2Widowed combined with separated/divorced in gender-specific models because of small numbers (C).
3Treated as missing in gender-specific models because of small numbers (M).
*p < .05; **p < .01; ***p < .001.
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the 2007 smoking rate of 14% in the province of British
Columbia, Canada [28]. The participants tended to be
heavy smokers who were highly dependent on nicotine.
Other researchers also have reported very high rates of
tobacco dependence among people with serious mental
illness [6], particularly those with schizophrenia [29].
What is particularly troubling about our findings is that
Vancouver is a region that has some of the strongest
tobacco control measures in Canada [30]. Although
these measures have been instrumental in reducing the
smoking rate to one of the lowest in Canada, a more
tailored approach with considerable support, including
pharmacological aid, social support and other resources,
is needed for community-based people with serious
mental illness.
We found that tobacco use rates varied by psychiatric
diagnosis (39.2% for those with mood and anxiety disor-
ders and 59.8% for those with schizophrenia), and that
diagnosis was only predictive of men’s smoking. The
overall rate is lower than what has been reported else-
where. It has been reported that, in Kentucky, the preva-
lence of current daily smoking for patients with bipolar
disorder and schizophrenia were 66% and 74%, respec-
tively [31]. This may point to the importance of the
social context in influencing the tobacco use of people
with serious mental illness. Kentucky, a tobacco produ-
cing state in the USA, is reported to have the highest
current smoking prevalence rate in the USA [32].
More men than women reported being current smo-
kers and the predictors of tobacco use varied by gender,
in the gender-stratified analysis we found differential
predictors of current smoking status. These findings
suggest that while strategies need to be found for people
with mental health issues, in general, services need to be
gender sensitive. Gender has historically been a factor in
tobacco use; men have been more likely to smoke than
have women. Although the gender gap in the general
population’s smoking rate is narrowing, there remains a
substantial differential in the smoking rates of men and
women with serious mental illness. More research is
needed of people with serious mental illness to untangle
the relationships among gender, psychiatric diagnosis,
the social context, and smoking status.
The specific needs of people with a diagnosis of schi-
zophrenia spectrum disorder are unique. For example,
they may require more support for cessation and they
may need education about how their negative symptoms
may interfere with some of the conventional methods of
cessation support such as group interaction. The finding
that smokers had higher rates of substance use than did
the non-smokers echoes the results of other researchers
and magnifies the overlap between tobacco use and
other substance use. Best practice guidelines recom-
mend that treatment for these co-occurring disorders be
integrated [33]. Although movement towards the
integration of mental health and addiction services is
gaining momentum, and more settings have begun to
successfully incorporate smoking cessation into their
practice [34], there is still much dispute among clini-
cians about whether tobacco use should be treated as an
addiction and considered part of the spectrum of sub-
stance use within the context of dual disorder services.
Many of the smokers in this study reported strategi-
cally using tobacco to cope with their psychiatric symp-
toms. Reports published elsewhere have discussed the
complicated roles nicotine and tobacco play in the lives
of people with mental illness [35]. The stimulating effect
of nicotine is known to modulate social and interperso-
nal factors to reduce anxiety and to relieve boredom.
Nicotine also alters the neurochemistry of the brain and
affects the rate at which psychotropic medications are
metabolised [35]. Clearly the use of tobacco has serious
implications for psychiatric recovery, which is a compel-
ling reason to advocate strongly for the clinical monitor-
ing of changes in tobacco use in clients.
Tobacco cessation support is a service that should be
offered to all clients wanting to stop smoking, and
smoking cessation interventions have been shown to be
effective in mentally ill clients residing in the commu-
nity [36]. The reason for the high smoking rates among
persons with mental illness may, in part, be related to
mental healthcare providers’ reluctance to integrate
interventions for tobacco reduction into their practice,
and the lack of attention given to tobacco dependence
in organizations providing services for the mentally ill.
Integrated solutions must include preparing mental
health providers to support tobacco reduction and
smoking cessation efforts.
It is clear that the economic costs of tobacco use place
a significant burden on people with serious mental ill-
ness, especially because many rely on government sub-
sistence, which is well below the poverty line [37]. At
the time of this survey, income from a disability pension
was capped at $856.42 per month. Social assistance for
a single person with a disability, provided by the Gov-
ernment of BC, was 62% of the low-income cut off
established by the federal government [38]. Smokers in
this study spent an average of $160 per month on
tobacco; almost 20% of their monthly income. In addi-
tion, many of the smokers made choices to smoke
“butts” and to buy cigarettes instead of food. It is well
documented that poverty is associated with poorer
health outcomes and the extra burden of tobacco-
related effects confounds these people’s already compro-
mised health outcomes. Tobacco use treatments have
been shown to be highly cost-effective [39]. Subsidizing
nicotine replacement therapy (NRT) is efficacious in sig-
nificantly increasing cessation rates and the number of
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cessation attempts by smokers wanting to stop smoking
[40]. In heavy smokers, higher doses of NRT have been
shown to increase cessation rates [41]. A way to reduce
both the physical and the economic burden of tobacco
is for governments or third-party health insurers to pro-
vide nicotine replacement therapeutic products free of
charge for people with serious mental illness.
These findings must be considered in light of several
methodological limitations. First, the relatively low parti-
cipation rate limits our ability to generalize to the com-
munity-based mental health population as a whole.
Other community-based studies of people with mental
illness have reported similar response rates [42,43].
There are specific factors associated with seriously men-
tally ill people’s willingness to engage in research
[44,45]. Many of these factors affected our ability to
recruit participants, including the lack of a supportive
research culture in the study settings and a reliance on
mental health team staff for client referral. Client-speci-
fic factors included a fear that the information provided
would not be kept confidential and would have an
impact on their healthcare. The length of the question-
naire may have been a barrier; many people believed
that they could not complete a 45-minute interview.
The presence of some symptoms (e.g., paranoia) may
have had an additional impact on recruitment. Another
limitation of the study relates to the accuracy of the
medical diagnosis data; 19% of the participants did not
permit access to their medical records. Our reliance on
self-reported diagnosis, for these case, may have resulted
in misclassification bias. Additionally, some confidence
intervals for the odds ratios were very wide (i.e., cocaine
use, being widowed, and having no housing) indicating a
lack of precision in these estimates.
Conclusion
People with serious mental illness have very high rates
of tobacco use and levels of nicotine dependence, and
bear a significant health and economic burden because
of their tobacco use. Many of the factors that are asso-
ciated with smoking vary by gender, and socio-environ-
mental factors play a key role. Researchers have
suggested that smoking, particularly by those with schi-
zophrenia, is likely the result of self-medication for
symptoms. Consistent with Srinivasan and Thara’s con-
clusions, we found that social factors, including where
one lives, and one’s marital status, education, and
sources of income are associated with smoking, which
suggests a more multifacted explanation of tobacco use
in the presence of mental illness is required [46]. The
finding that gender is strongly associated with smoking
status may be explained by a biological sex-based factor
or it may represent further support for the hypothesis
that social determinants are significant factors at play.
More work must be undertaken to better understand
the motivators and reinforcers of tobacco use in this
population and to develop appropriate tobacco cessation
interventions.
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